Endymed Ltd (TLV: ENDY)

Market Cap	38.91M
Revenue (ttm)	70.42M
Net Income (ttm)	-6.76M
Shares Out	13.76M
EPS (ttm)	-0.49
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,473
Open	290.70
Previous Close	290.70
Day's Range	279.70 - 290.70
52-Week Range	190.00 - 355.00
Beta	-0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 20, 2025

About Endymed

Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Its products comprise EndyMed PRO, a multi-application treatment platform; PURE 2.0 that offers professional skin tightening, body contouring, and functional resurfacing; and 3DEEP radiofrequency technology, a solution for the treatment of skin tightening, wrinkle reduction, RF micro needling, and fractional skin resurfacing. The company was incorporated in 2004 an...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 46
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: ENDY

Financial Performance

In 2023, Endymed's revenue was $22.78 million, an increase of 6.77% compared to the previous year's $21.33 million. Earnings were $553,000, a decrease of -34.94%.

Financial numbers in USD